Live Quote · NASDAQIMTXHealthcare· Biotechnology

Immatics N.V.

$5.77▼ 3.03%($-0.18)
MKT CAP $863.40MNEXT EARNINGS Mar 4, 2027
50%
Bullish
TickerSpark Score
46/100
▌ Weak
65
Valuation
40
Profitability
10
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMTX research report →

Analyst Price Target
$17.67+206.2% vs. today

Range $15 – $21

Analyst RatingBuy
8 Buy0 Hold0 Sell

Price Chart

-42.87% · this period
$11.87$8.82$5.77Nov 20May 26Nov 20
52-Week Range1% of range
Low
$5.71
Current
$5.77
High
$12.41